Assessment of Clopidogrel Resistance in Post Myocardial Infarction Patients after 24 to 48 Hours of Initiation of Treatment: A Cross-sectional Study
Introduction: Clopidogrel is an antiplatelet agent used to prevent platelet aggregation and further blockage of coronary arteries in Acute Coronary Syndrome (ACS) patients. Inadequate response to clopidogrel has been demonstrated in some patients that might lead to re-infarction even when receiv...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2021-07-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/15171/49310_CE[Ra1]_F[SK]_PF1(SC_RK)_PFA(KM_Pr)_PN(KM).pdf |